ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 755264 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 755264; 2) Community: the network communities that were significantly associated with the response to NSC 755264; 3) Molecule: the relationships between components within communities and NSC 755264; 4) MDR: the compounds that were significantly associated with the NSC 755264.

NSC Compound Enrichment Correlation
NSC 303861 L-Cysteine analog 0.0041872854493286 0.4457601
NSC 328477 3'-Chloro-3-nitro-o-salicylotoluidide 0.0041872854493286 0.078893388
NSC 33570 Null 0.0041872854493286 0.28410318
NSC 339579 7H-Pyrrolo[3,2-f]quinazoline-2,4-diamine, 7-[(3-nitrophenyl)methyl]-, monoacetate 0.0041872854493286 0.44635657
NSC 351521 Ethanesulfonic acid, 2-hydroxy-, compd. with 6-[(2,5-dimethoxyphenyl)methyl]-5-methylpyrido[2,3-d] pyrimidine-2,4-diamine (1:1) 0.0041872854493286 0.54038368
NSC 359239 Antibiotic X-14766A 0.0041872854493286 0.1701473
NSC 371777 Null 0.0041872854493286 0.14125522
NSC 372155 2-Propenamide, N-[(cyanoamino)iminomethyl]-2-methyl- 0.0041872854493286 0.10712815
NSC 42972 Null 0.0041872854493286 0.36635555
NSC 614887 Platinum, (1,2-cyclohexanediamine-N,N')bis (4-morpholinepropanesulfonato-O)-, (SP-4-2) 0.0041872854493286 0.40471202
Total:158  Current:22    [First] [Prev] [Next] [Last]